Centene Corporation (CNC) continues to hold a strong position in the health insurance market despite recent market oscillations and certain uncertainties in Medicare and Medicaid sectors. Despite some shares being sold off by entities such as State of Alaska Department of Revenue and Forsta AP Fonden, other institutional investors have increased their holdings, indicating mixed sentiment. In Q4 2024, the company posted strong EPS and revenue numbers, which were above Wall Street estimates. Furthermore, the company's stock slid 4% post Q4 earnings call due to certain market factors, it was also downgraded to Hold at Argus. Centene updated its FY 2025 earnings guidance and, despite a decline in Q4, reaffirmed its 2024 earnings projections. The financials for 2024 were reported to be strong, and the company expects a $4B increase in revenue guidance for 2025 while maintaining its EPS target. The firm's resilience, despite stock market fluctuations gives a sense of strong fundamentals. It's noteworthy that the company has been listed as one of the large-cap stocks insiders are buying recently, and has been named one of Fortune's 100 Best Large Workplaces for Women 2024.
Centene Corporation CNC News Analytics from Fri, 26 Jul 2024 07:00:00 GMT to Sat, 08 Feb 2025 21:02:00 GMT -
Rating -1
- Innovation 0
- Information 8
- Rumor -2
